1 to 9 of 40 results

Actavis forks out $100 million for Thai generics firm

Actavis forks out $100 million for Thai generics firm


Ireland-headquartered US generic major Actavis has acquired Silom Medical Company, a privately held generic…

Asia-PacificAurobindo PharmaGenericsMergers & AcquisitionsSilom Medical CompanyTeva Pharmaceutical Industries

Israel's Clal Biotech in talks to sell Andromeda unit


In an announcement to the Stock Exchange, Israeli firm Clal Biotechnology Industries said that, on February…

Andromeda BiotechBiotechnologyClal BiotechnologyDiabetesDiaPep277Mergers & AcquisitionsTeva Pharmaceutical Industries

NuPathe accepts Teva’s higher counter bid, rejecting Endo offer


Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

NuPathe receives counter offer from Teva topping Endo bid


US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

ANI Pharma buys 31 generic drugs from Teva

ANI Pharma buys 31 generic drugs from Teva


Emerging US generic drugmaker ANI Pharmaceuticals says that it has acquired 31 previously marketed generic…

ANI PharmaceuticalsGenericsMergers & AcquisitionsTeva Pharmaceutical Industries

Teva and Lonza to discontinue their biosimilars collaboration


Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Teva to expand respiratory business with up to $165 million acquisition of MicroDose Therapeutx


Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) has entered into a definitive agreement to acquire…

Mergers & AcquisitionsMicroDose TherapeutxPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

News briefs: US Crestor patent upheld; Pfizer animal health plans; Teva South Korea JV


Anglo-Swedish drug major AstraZeneca (LSE: AZ) said on Friday that the US Court of Appeals for the Federal…

Asia-PacificAstraZenecaCrestorGenericsHandok PharmaceuticalsLegalMergers & AcquisitionsNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesZoetis

1 to 9 of 40 results

Back to top